NCT04197804

Brief Summary

The study intends to evaluate the role of Mirror Neurons in the determination of gestures, words, and repetitive vocalizations in subjects affected by Tourette's syndrome and to verify if these subjects are faster to assemble sounds, in phonology and morphology, than the non-pathological population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

December 13, 2019

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

12 months

First QC Date

December 29, 2018

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tourette syndrome and the imitation of gestures

    The aim is to investigate the correlation between Mirror Neurons and Tourette Syndrome defining the greater propensity of the Tourettian subjects to imitate gestures, through the administration of the first Task

    Through study completion, an average of 1 year

Study Arms (2)

Tourette group

20 subjects with Tourette Syndrome undergoing an evaluation to identify the IQ. Subsequently, 4 tasks are presented. The 1st (with a duration of about 2 and a half minutes) and the 2nd (with a duration of about 2 minutes) concerning the motor field, the 3rd (with duration of about 1 minute) and the 4th (with duration of about 3 minutes) concerning the linguistic field.

Other: Routine tests perform

Control group

20 subjects without Tourette Syndrome subjected to an evaluation to identify the IQ. Subsequently 4 tasks are presented. The 1st (with a duration of about 2 and a half minutes) and the 2nd (with a duration of about 2 minutes) concerning the motor field, the 3rd (with duration of about 1 minute) and the 4th (with duration of about 3 minutes) concerning the linguistic field.

Other: Routine tests perform

Interventions

The subjects of the Tourette group and control group are subjected to routine tests performed at Tourette Center and Extrapyramidal Diseases. Both groups are initially subjected to an evaluation that aims to identify the IQ and therefore 4 tasks are presented. The 1st (with a duration of about 2 and a half minutes) and the 2nd (with a duration of about 2 minutes) related to the motor field, the 3rd (with duration of about 1 minute) and the 4th (with duration about 3 minutes) the language field. These evaluations are in practice at the Center for Tourette patients; the tasks will be administered to both groups.

Control groupTourette group

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

The calculated sample size is 20 subjects per arm considering: 1. error of I type with two queues = 0.05; 2. Type II error β = 0.20, which corresponds to a test power (1-β = 0.80) of 80%; 3. a clinically significant difference of 4%;

You may qualify if:

  • TOURETTE GROUP
  • Consecutive patients belonging to the Tourette Center
  • Caucasian
  • Italian mother-tongue
  • Age between 6 and 10 years completed
  • Male and female 4: 1 (16 males and 4 females)
  • Diagnosis of Tourette's syndrome for at least 1 year
  • Presence of a value of YGTSS\> 50%
  • NOT GROUP TOURETTE
  • Caucasian
  • Italian mother-tongue
  • Age between 6 and 10 years completed
  • Male and female 4: 1 (16 males and 4 females)

You may not qualify if:

  • TOURETTE GROUP
  • Diagnosis of DSA
  • Presence of significant psychiatric disorders, with the exception of those belonging to the Tourette Syndrome itself (eg ADHD, OCD).
  • NOT GROUP TOURETTE
  • Diagnosis of DSA
  • Presence of significant psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, Italy

Location

MeSH Terms

Conditions

Tourette Syndrome

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Mauro Porta

    IRCCS Istituto Ortopedico Galeazzi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2018

First Posted

December 13, 2019

Study Start

May 2, 2018

Primary Completion

April 30, 2019

Study Completion

April 30, 2019

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations